Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
By Marleen Kaesebier and Patricia Weiss ZURICH, April 22 (Reuters) – Swiss drugmaker Roche on Wednesday said it…
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
F. Hoffmann-La Roche Ltd Group sales were +6% at constant exchange rates (CER)1, -5% when reported in CHF and…
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
F. Hoffmann-La Roche Ltd Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib…
Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
By Marleen Kaesebier and Patricia Weiss ZURICH, April 22 (Reuters) – Swiss drugmaker Roche on Wednesday said it…
Roche’s fenebrutinib cuts relapses in MS amid safety concerns
Roche is hoping to bring the the first and only high-efficacy oral for both relapsing multiple sclerosis (RMS)…
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
F. Hoffmann-La Roche Ltd The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed…
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
F. Hoffmann-La Roche Ltd The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed…
Roche Receives CE Mark for Multiple Sclerosis Blood Test
Roche has received the CE mark for its Elecsys Neurofilament Light Chain (NfL) for the detection of neuroinflammation…
French court sentences Islamic scholar to 18 years in prison for rape
Swiss Islamic scholar Tariq Ramadan was sentenced on Wednesday to 18 years in prison by a Paris criminal…
French court finds Swiss Islamic scholar Ramadan guilty of rape
Swiss Islamic scholar Tariq Ramadan was sentenced on Wednesday to 18 years in prison by a Paris criminal…
Genentech fenebrutinib slashes MS relapses 51%
03/02/2026 – 01:10 AM – FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by…
Roche India partners with Punjab Govt to strengthen Multiple Sclerosis care
Roche India partners with Punjab Govt to strengthen Multiple Sclerosis care March 11, 2026 | Wednesday | News…